MONTREAL, May 7, 2013 /CNW Telbec/ - Valeo Management and its exclusive
worldwide licensee FITTnLEAN, which markets Adipotronics, the patented
targeted fat loss technology, announce the closing of a $1,000,000
investment by Partner One Capital.
The technology uses an electrical stimulator, which induces targeted fat
loss through a gentle electric current in areas designated by the user
during physical activity. It was invented by researchers from the
Departments of Kinanthropology and Biological Sciences of the
University of Québec at Montréal (UQAM).
In 2012, FITTnLEAN successfully completed a 10-week triple-blind,
randomized, placebo-controlled clinical study on the Adipotronics
technology, showing impressive targeted fat loss results.
FITTnLEAN will be launching Adipotronics, the targeted fat loss
technology, in late 2013.
FITTnLEAN is the exclusive worldwide licensee of Adipotronics, the
targeted fat loss technology. FITTnLEAN specializes in the development
and commercialization of patented and/or innovative products and
services in the areas of health, fitness and aesthetics. (www.FittnLean.com)
About Partner One Capital
With current assets of $1.4 Billion, Partner One Capital is currently
the world's largest self-funded private investment firm focusing solely
on marketing-driven businesses. Since 1995, Partner One Capital has
established itself as a leading investment firm and partner, with a
solid track record of success in private equity, venture capital and
angel investments. (www.PartnerOneCapital.com)
SOURCE: Valeo Management
For further information: